Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.40 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | CPA1 | P15085 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | ANPEP | P15144 | 2/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31064905 | 0.98 | ALDH1A1 (0.44) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29723604 | 0.91 | BACE1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL30099503 | 0.91 | OPRD1 (0.43) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL31258959 | 0.88 | MME (0.44) | MMEACECPA1ACE2 | |
| SCHEMBL620370 | 0.88 | SLC7A5 (0.54) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL620369 | 0.88 | SLC7A5 (0.54) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL6047667 | 0.88 | SLC7A5 (0.54) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL11788108 | 0.87 | SLC7A5 (0.41) | SLC7A5OPRD1OPRM1OPRK1LARS1 | |
| SCHEMBL11788120 | 0.87 | SLC7A5 (0.41) | SLC7A5OPRD1OPRM1OPRK1LARS1 | |
| SCHEMBL11664472 | 0.86 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114958797-A | Mutant DNA polymerase, coding gene, recombinant expression vector, recombinant bacterium and application thereof | 郑州思昆生物工程有限公司 | 2022-08-30 | — | — | CN | claimed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| CN-114958797-B | Mutant DNA polymerase, coding gene, recombinant expression vector, recombinant bacterium and application thereof | 郑州思昆生物工程有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119490563-A | Bird's nest peptide for promoting silk fibroin and inhibiting expression of inflammatory factors | 厦门市燕之屋丝浓生物科技有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-119390781-A | Polypeptide specifically binding to Nectin-4 and application thereof | 湖南中晟全肽生物科技股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119345324-A | Structure and application of bird's nest monopeptide for enhancing and improving lung function and preventing pulmonary fibrosis | 厦门市燕之屋丝浓生物科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119119249-A | Binding protein comprising AAV-9 antigen binding domain | 杭州艾策生物技术有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118853640-A | Carbapenem drug-resistant gene and application thereof | 郑州大学 | 2024-10-29 | — | — | CN | disclosed |
| US-20240299562-A1 | COMPOUNDS COMPRISING A TETRAPEPTIDIC MOIETY | COBIORES NV (BE) | 2024-09-12 | — | — | US | disclosed |
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | COBIORES NV (BE) | 2024-04-18 | — | — | US | disclosed |
| US-11939369-B2 | Integrin antagonists | THE GENERAL HOSPITAL CORPORATION (US) | 2024-03-26 | — | — | US | disclosed |
| EP-4267188-A1 | COMPOUNDS COMPRISING A TETRAPEPTIDIC MOIETY | Cobiores NV (BE) | 2023-11-01 | — | — | EP | disclosed |
| CN-116635054-A | Compounds comprising tetrapeptide moieties | 科比欧尔斯公司 | 2023-08-22 | — | — | CN | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| CN-114958797-A | Mutant DNA polymerase, coding gene, recombinant expression vector, recombinant bacterium and application thereof | 郑州思昆生物工程有限公司 | 2022-08-30 | — | — | CN | disclosed |
| WO-2022167664-A1 | COMPOUNDS COMPRISING A TETRAPEPTIDIC MOIETY | COBIORES NV (BE) | 2022-08-11 | — | — | WO | disclosed |
| WO-2022136586-A1 | COMPOUNDS COMPRISING A TETRAPEPTIDIC MOIETY | COBIORES NV (BE) | 2022-06-30 | — | — | WO | disclosed |
| US-20220153812-A1 | INTEGRIN ANTAGONISTS | THE GENERAL HOSPITAL CORPORATION | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11939369-B2 | Integrin antagonists | ITGB3, ITGA2B, ITGB1 | ALDH1A1 1940/4885LMNA 3167/4885MAPT 4662/4885 |
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | ALDH1A1 3596/4885LMNA 1538/4885MAPT 3330/4885 |
| US-20240123074-A1 | MINIMALLY TOXIC PRODRUGS | ALG8, ALG1, LNPEP | ALDH1A1 1676/4885LMNA 2409/4885MAPT 2710/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | ALDH1A1 4110/4885LMNA 3184/4885MAPT 4191/4885 |
| US-20220153812-A1 | INTEGRIN ANTAGONISTS | ITGB3, ITGA2B, ITGB1 | ALDH1A1 1940/4885LMNA 3167/4885MAPT 4662/4885 |
| US-20240299562-A1 | COMPOUNDS COMPRISING A TETRAPEPTIDIC MOIETY | DNPEP, NPEPPS, ENPEP | ALDH1A1 1998/4885LMNA 2734/4885MAPT 4442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.